Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Esselin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Revue Neurologique|December 12, 2022
Therapeutic tools for familial ALSW Camu, E De La Cruz, F Esselin
European Journal of Neurology|August 23, 2019
Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosisE Thouvenot, C Demattei, S Lehmann, et al.
Revue Neurologique|May 21, 2026
Primary Lateral Sclerosis French National Diagnostic and Care ProtocolP Corcia, E Bernard, E de la Cruz, et al.
European Journal of Neurology|August 2, 2025
Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS StudyP Corcia, D Erazo, M D M Amador, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Revue Neurologique|December 12, 2022
Therapeutic tools for familial ALSW Camu, E De La Cruz, F Esselin
European Journal of Neurology|August 23, 2019
Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosisE Thouvenot, C Demattei, S Lehmann, et al.
Revue Neurologique|May 21, 2026
Primary Lateral Sclerosis French National Diagnostic and Care ProtocolP Corcia, E Bernard, E de la Cruz, et al.
European Journal of Neurology|August 2, 2025
Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS StudyP Corcia, D Erazo, M D M Amador, et al.
Pageof 1